{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:28:06Z","timestamp":1792301286617,"version":"4.4.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00532","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T04:29:14Z","timestamp":1553142554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Harindra D.","family":"Sathkumara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saparna","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel de Jes\u00fas","family":"Aceves-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natkunam","family":"Ketheesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Alberto","family":"Flores-Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kupz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"B1","unstructured":"Global Tuberculosis Report.2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O'Garra","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12762","article-title":"Influence of diabetes mellitus on immunity to human tuberculosis","volume":"152","author":"Kumar Nathella","year":"2017","journal-title":"Immunology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol."},{"key":"B5","year":"2013","journal-title":"Global Report: UNAIDS Report on the Global AIDS Epidemic."},{"key":"B6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: success through dormancy","volume":"36","author":"Gengenbacher","year":"2012","journal-title":"FEMS Microbiol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fimmu.2017.00407","article-title":"Immune responses to bacillus calmette-guerin vaccination: why do they fail to protect against mycobacterium tuberculosis?","volume":"8","author":"Moliva","year":"2017","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/trstmh\/tru206","article-title":"Aerosol immunisation for TB: matching route of vaccination to route of infection","volume":"109","author":"Manjaly Thomas","year":"2015","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/fvl.12.123","article-title":"HIV-1 and the immune response to TB","volume":"8","author":"Walker","year":"2013","journal-title":"Future Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"E5636","DOI":"10.1073\/pnas.1611987113","article-title":"CD4+ T-cell\u2013independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection","volume":"113","author":"Foreman","year":"2016","journal-title":"Proc Nat Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/infdis\/jix625","article-title":"High turnover of tissue macrophages contributes to tuberculosis reactivation in simian immunodeficiency virus-infected rhesus macaques","volume":"217","author":"Kuroda","year":"2018","journal-title":"J Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coi.2017.06.007","article-title":"BCG - old workhorse, new skills","volume":"47","author":"Gengenbacher","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"276fs8","DOI":"10.1126\/scitranslmed.aaa4730","article-title":"Tuberculosis vaccines: time for a global strategy","volume":"7","author":"Kaufmann","year":"2015","journal-title":"Sci Transl Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.12688\/f1000research.13588.1","article-title":"Progress and challenges in TB vaccine development","volume":"7","author":"Voss","year":"2018","journal-title":"F1000Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.smim.2013.04.006","article-title":"Tuberculosis vaccines: time to think about the next generation","volume":"25","author":"Kaufmann","year":"2013","journal-title":"Semin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3389\/fimmu.2017.01203","article-title":"TBVAC2020: advancing tuberculosis vaccines from discovery to clinical development","volume":"8","author":"Kaufmann","year":"2017","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/joim.12212","article-title":"Recent advances towards tuberculosis control: vaccines and biomarkers","volume":"275","author":"Weiner","year":"2014","journal-title":"J Int Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/mi.2013.99","article-title":"Harnessing local and systemic immunity for vaccines against tuberculosis","volume":"7","author":"Beverley","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1590\/0074-0276140091","article-title":"Oral bacillus Calmette-Guerin vaccine against tuberculosis: why not?","volume":"109","author":"Monteiro-Maia","year":"2014","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1128\/CVI.00700-13","article-title":"Pulmonary Mycobacterium bovis. BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination","volume":"21","author":"Aguilo","year":"2014","journal-title":"Clin Vacc Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e01686","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis","volume":"7","author":"Perdomo","year":"2016","journal-title":"mBio."},{"key":"B26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fimmu.2018.00121","article-title":"Next-generation vaccines based on bacille calmette-guerin","volume":"9","author":"Nieuwenhuizen","year":"2018","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant bacille calmette-guerin vaccine vpm1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3389\/fimmu.2017.01803","article-title":"MTBVAC: Attenuating the human pathogen of Tuberculosis (TB) toward a promising vaccine against the TB epidemic","volume":"8","author":"Gonzalo-Asensio","year":"2017","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1016\/j.vaccine.2016.08.035","article-title":"The BCGDeltaBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo","volume":"34","author":"Pedroza-Roldan","year":"2016","journal-title":"Vaccine."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","article-title":"Recombinant BCG expressing ESX-1 of mycobacterium marinum combines low virulence with cytosolic immune signaling and improved tb protection","volume":"18","author":"Groschel","year":"2017","journal-title":"Cell Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.vaccine.2015.01.058","article-title":"Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis","volume":"33","author":"Sander","year":"2015","journal-title":"Vaccine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.vaccine.2013.12.055","article-title":"BCG Deltazmp1 vaccine induces enhanced antigen specific immune responses in cattle","volume":"32","author":"Khatri","year":"2014","journal-title":"Vaccine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"8533","DOI":"10.1038\/ncomms9533","article-title":"Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis","volume":"6","author":"Kaushal","year":"2015","journal-title":"Nat Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis \u0394RD1 \u0394panCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine."},{"key":"B35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/iub.1353","article-title":"The Cyclic Di-GMP phosphodiesterase gene Rv1357c\/BCG1419c affects bcg pellicle production and in vivo maintenance","volume":"67","author":"Flores-Valdez","year":"2015","journal-title":"IUBMB Life."},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fmicb.2016.00014","article-title":"Vaccines directed against microorganisms or their products present during biofilm lifestyle: can we make a translation as a broad biological model to tuberculosis?","volume":"7","author":"Flores-Valdez","year":"2016","journal-title":"Front. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3389\/fmicb.2018.01281","article-title":"The BCG\u0394BCG1419c vaccine candidate reduces lung pathology, IL-6, TNF-\u03b1, and IL-10 during chronic TB infection","volume":"9","author":"Flores-Valdez","year":"2018","journal-title":"Front Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.vaccine.2018.03.014","article-title":"Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence","volume":"36","author":"Segura-Cerda","year":"2018","journal-title":"Vaccine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21390","article-title":"Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK","volume":"21","author":"Mangtani","year":"2017","journal-title":"Health Technolo Assess."},{"key":"B42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","article-title":"Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study","volume":"16","author":"Nguipdop-Djomo","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1\u2013372","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess."},{"key":"B44","doi-asserted-by":"publisher","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ."},{"key":"B45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/thoraxjnl-2012-202208","article-title":"Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates","volume":"68","author":"Chan","year":"2013","journal-title":"Thorax."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/thoraxjnl-2017-211124","article-title":"Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort","volume":"74","author":"Jackson","year":"2019","journal-title":"Thorax."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22560","article-title":"Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study","volume":"22","author":"Abubakar","year":"2018","journal-title":"Health Technol Assess."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e73069","DOI":"10.1371\/journal.pone.0073069","article-title":"Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS ONE."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLoS Pathog."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0158849","DOI":"10.1371\/journal.pone.0158849","article-title":"A mouse model of latent tuberculosis infection to study intervention strategies to prevent reactivation","volume":"11","author":"Kupz","year":"2016","journal-title":"PLoS ONE."},{"key":"B52","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.4049\/jimmunol.162.9.5407","article-title":"Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis","volume":"162","author":"Caruso","year":"1999","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1473-3099(13)70253-6","article-title":"Is tuberculosis a lymphatic disease with a pulmonary portal?","volume":"14","author":"Behr","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e0169119","DOI":"10.1371\/journal.pone.0169119","article-title":"Human and mouse hematopoietic stem cells are a depot for dormant Mycobacterium tuberculosis","volume":"12","author":"Tornack","year":"2017","journal-title":"PLoS ONE."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/infdis\/jiy041","article-title":"Mycobacterium tuberculosis-infected hematopoietic stem and progenitor cells unable to express inducible nitric oxide synthase propagate tuberculosis in mice","volume":"217","author":"Reece","year":"2018","journal-title":"J Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"170ra13","DOI":"10.1126\/scitranslmed.3004912","article-title":"CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis","volume":"5","author":"Das","year":"2013","journal-title":"Sci Transl Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.ajpath.2015.03.028","article-title":"Preclinical and clinical evidence of Mycobacterium tuberculosis persistence in the hypoxic niche of bone marrow mesenchymal stem cells after therapy","volume":"185","author":"Garhyan","year":"2015","journal-title":"Am J Pathol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1007337","DOI":"10.1371\/journal.ppat.1007337","article-title":"Lymph nodes are sites of prolonged bacterial persistence during Mycobacterium tuberculosis infection in macaques","volume":"14","author":"Ganchua","year":"2018","journal-title":"PLoS Pathog."},{"key":"B59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jim.2006.09.013","article-title":"A general method for bead-enhanced quantitation by flow cytometry","volume":"317","author":"Montes","year":"2006","journal-title":"J Immunol Methods."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1172\/JCI84978","article-title":"ESAT-6\u2013dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo","volume":"126","author":"Kupz","year":"2016","journal-title":"J Clin Invest."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1007060","DOI":"10.1371\/journal.ppat.1007060","article-title":"Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages","volume":"14","author":"Yang","year":"2018","journal-title":"PLoS Pathog."},{"key":"B62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.coi.2018.04.004","article-title":"Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis","volume":"53","author":"Achkar","year":"2018","journal-title":"Curr Opin Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell."},{"key":"B64","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1073\/pnas.1611776114.","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Nat Acad Sci. USA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1005687","DOI":"10.1371\/journal.ppat.1005687","article-title":"Patients with tuberculosis have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment","volume":"12","author":"Joosten","year":"2016","journal-title":"PLOS Pathog."},{"key":"B68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.immuni.2006.10.002","article-title":"B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization","volume":"24","author":"Angeli","year":"2006","journal-title":"Immunity."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00532\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:33:19Z","timestamp":1694716399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00532\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2019.00532"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00532","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"article-number":"532"}}